Direct : 604-802-7759   


Royal LePage's Q1 2023 Home Price Update and Market Forecast

Royal LePage's Q1 2023 Home Price Update and Market Forecast

The Royal LePage Home Price Update and Market Forecast was distributed to the media early this morning. The release, distributed each quarter, includes price data and insights from experts in 62 real estate markets across the country, as well as national and regional forecasts.


Key highlights from the release include:

  • National aggregate home price forecast to increase 4.5% year-over-year in Q4 2023

  • Single-digit price gains in first quarter driven by early return of sidelined buyer demand and continued shortage of inventory

  • National aggregate home price up 2.8% quarter-over-quarter in Q1 2023; down 9.2% over same period in 2022

  • Greater regions of Toronto, Montreal and Vancouver post quarterly aggregate price gains of 4.8%, 1.3% and 1.3%, respectively in the first quarter

  • Royal LePage urges OSFI to heed the economic dangers that would accompany new, aggressive mortgage restrictions

A big thank you to all of our spokespeople across the country who provided regional perspectives.

Use the buttons below to read the full national release, find regional insights and view the comprehensive data charts.


No comments

Post Your Comment:

Your email will not be published
Reciprocity Logo The data relating to real estate on this website comes in part from the MLS® Reciprocity program of either the Greater Vancouver REALTORS® (GVR), the Fraser Valley Real Estate Board (FVREB) or the Chilliwack and District Real Estate Board (CADREB). Real estate listings held by participating real estate firms are marked with the MLS® logo and detailed information about the listing includes the name of the listing agent. This representation is based in whole or part on data generated by either the GVR, the FVREB or the CADREB which assumes no responsibility for its accuracy. The materials contained on this page may not be reproduced without the express written consent of either the GVR, the FVREB or the CADREB.